CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
FGGBX
Price
$3.12
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
331.17M
Interact to see
Advertisement

CIMCX vs FGGBX

Header iconCIMCX vs FGGBX Comparison
Open Charts CIMCX vs FGGBXBanner chart's image
CIMCX vs FGGBX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. FGGBX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and FGGBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. FGGBX (331M). FGGBX pays higher dividends than CIMCX: FGGBX (6.11) vs CIMCX (2.73). CIMCX was incepted earlier than FGGBX: CIMCX (24 years) vs FGGBX (13 years). CIMCX (1.35) is less costly to investors than FGGBX (0.96). CIMCX is a more actively managed with annual turnover of: 65.00 vs. FGGBX (50.24). CIMCX has a lower initial minimum investment than FGGBX: CIMCX (250) vs FGGBX (1000000). FGGBX annual gain was more profitable for investors over the last year : 26.25 vs. CIMCX (8.06). FGGBX return over 5 years is better than : 28.90 vs. CIMCX (20.12).
CIMCXFGGBXCIMCX / FGGBX
Total Expense Ratio1.350.89152%
Annual Report Gross Expense Ratio1.350.96141%
Fund Existence24 years13 years-
Gain YTD5.6549.37160%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets147B331M44,411%
Annual Yield % from dividends2.736.1145%
Returns for 1 year8.0626.2531%
Returns for 3 years33.0753.0762%
Returns for 5 years20.1228.9070%
Returns for 10 years67.7057.11119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C